SCHEMBL31542074

SCHEMBL31542074

O=C(NC1CC1)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
CTSD P07339 1/20 0.61
L3MBTL1 Q9Y468 3/20 0.60
TDP1 Q9NUW8 3/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
PPIA P62937 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
ALPL P05186 1/20 0.52
GAA P10253 1/20 0.52
HTT P42858 1/20 0.52
NCOA1 Q15788 1/20 0.52
NCOA3 Q9Y6Q9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670667 1.00 ALDH1A1 (0.65) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13162530 0.94 ALDH1A1 (0.59) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL4959078 0.94 ALDH1A1 (0.59) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL4959067 0.94 ALDH1A1 (0.59) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13163089 0.94 ALDH1A1 (0.61) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13634257 0.93 ALDH1A1 (0.58) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL15888546 0.93 ALDH1A1 (0.58) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13634180 0.92 ALDH1A1 (0.61) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13634235 0.92 ALDH1A1 (0.56) ALDH1A1CTSDL3MBTL1TDP1KMT2A
SCHEMBL13162533 0.92 MAPT (0.60) ALDH1A1CTSDL3MBTL1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed